![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aníbal García-Sempere, Isabel Hurtado, José Sanfélix-Genovés, Clara Rodríguez-Bernal, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2019) Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs. Current Medical Research and Opinion 35:9, pages 1535-1544.
Read now
Read now
Peyman Hadji, Louis Jacob & Karel Kostev. (2016) Gender- and age-related treatment compliance in patients with osteoporosis in Germany. Patient Preference and Adherence 10, pages 2379-2385.
Read now
Read now
Articles from other publishers (10)
Faisal I. Almohaileb & Zafar Rasheed. (2022) Comparing the Efficacies of Bisphosphonates’ Therapies for Osteoporosis Persistence and Compliance: A Systematic Review. Current Molecular Medicine 22:3, pages 274-284.
Crossref
Crossref
Deborah T. Gold. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
1695
1707
.
Stuart L. Silverman, E. Siris, D. Belazi, C. Recknor, A. Papaioannou, J. P. Brown, D. T. Gold, E. M. Lewiecki, G. Quinn, A. Balasubramanian, S. Yue, B. Stolshek & D. L. Kendler. (2018) Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study. Archives of Osteoporosis 13:1.
Crossref
Crossref
C. T. Yeam, S. Chia, H. C. C. Tan, Y. H. Kwan, W. Fong & J. J. B. Seng. (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporosis International 29:12, pages 2623-2637.
Crossref
Crossref
Hideaki Kishimoto & Masayuki Maehara. (2015) Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Archives of Osteoporosis 10:1.
Crossref
Crossref
L. Karlsson, J. Lundkvist, E. Psachoulia, M. Intorcia & O. Ström. (2015) Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis. Osteoporosis International 26:10, pages 2401-2411.
Crossref
Crossref
Yihua Xu, Hema N. Viswanathan, Melea A. Ward, Brad Clay, John L. Adams, Bradley S. Stolshek, Joel D. Kallich, Shari Fine & Kenneth G. Saag. (2013) Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan. Journal of Evaluation in Clinical Practice 19:1, pages 50-59.
Crossref
Crossref
Sally W. Wade, Jeffrey R. Curtis, Jingbo Yu, Jeffrey White, Bradley S. Stolshek, Claire Merinar, Akhila Balasubramanian, Joel D. Kallich, John L. Adams & Hema N. Viswanathan. (2012) Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone 50:4, pages 870-875.
Crossref
Crossref
Stuart L. Silverman. (2010) Osteoporosis Therapies: Evidence from Health-Care Databases and Observational Population Studies. Calcified Tissue International 87:5, pages 375-384.
Crossref
Crossref
Suzanne M Cadarette & Andrea M Burden. (2010) Measuring and improving adherence to osteoporosis pharmacotherapy. Current Opinion in Rheumatology 22:4, pages 397-403.
Crossref
Crossref